NWPF

News ArchivesRead News

Parkinsons Disease Patches

Thursday February 25, 2010

Anita Choudhary

Parkinson's Disease Society - As a good method of treatment, Parkinson’s disease patch is being developed for treating Parkinson’s disease. This is being developed as a good method of treating it orally. The need to develop a skin patch for Parkinson’s existed, due to the digestive tract of people affected by the disease.

Skin patches are available for smoking cessation, heart problems, and pain control. A major research is going on for exploring new ways of treatment except oral medicines, of Parkinson’s.

The silicon patch that is being used in the clinical trials have Dopamine agonist , a drug commonly used to reduce the symptoms and help people lead a more normal life. ‘Neupro’ is the first trans-dermal patch that has been approved to treat symptoms of Parkinson’s disease.

The main symptoms of Parkinson’s include memory loss, decrease of cognitive skills, dementia. As it is a disorder of the central nervous system, motor skills are lost over time. These Parkinson’s disease patch medicines help in prolonging normal activity and suppressing the symptoms of the disease.

The main symptoms of this disease include stiffness and tremors in the limbs which is due to the reduction of Dopamine, chemical in the brain which controls movement in the body. Dopamine agonists clone dopamine and also stimulate the cells of the brain, just the way the normal chemical reacts.

Another Parkinsons disease patch that has been marketed is an active ingredient Rotigotine, which is a Dopamine receptor delivered through a skin patch. It is applied once to the skin and releases Ritigotine throughout 24 hours. Every day the patch needs to be changed. It is delivered to maintain stable rotigotine plasma in concentration level. The oral Dopamine agonists come in multiple doses but a patch is more effective and easy.

Recent News

Jun 13 - Brain Cell Transplants Are Being Tested Once Again For Parkinson's
Jun 12 - Smell Test May Sniff Out Oncoming Parkinson's and Alzheimer's
Jun 8 - Smartphones Track Motor Function in Parkinson's Disease
Jun 8 - GKC Enrolls First Patient in Personal KinetiGraph Trial as Part of NPF’s Parkinson’s Outcomes Project
Jun 8 - Low-fat dairy intake may raise Parkinson's risk
Jun 6 - Patient Voices: Parkinson's Disease
Jun 1 - World-First Trials Have Been Launched to Treat Parkinson's And Blindness With Embryonic Stem Cells
May 24 - Survival Rates Differ Widely in Parkinson's, MSA, Lewy Bodies
May 22 - Discovery may offer hope to Parkinson's disease patients
May 15 - Study offers answers on life expectancy for people with Parkinson's disease, Lewy body dementia
May 5 - Parkinson's in a dish: Researchers reproduce brain oscillations
May 5 - ‘Hunger Hormone’ Could Help Treat Parkinson’s Disease
May 3 - Antibiotic doxycycline may offer hope for treatment of Parkinson's disease
May 1 - Impulse Control Disorders in Parkinson's Disease: Building Physician, Patient Awareness
Apr 28 - Does Parkinson’s disease begin in the gut?
Apr 28 - New empathy-creating digital device could be revolutionary for caregivers
Apr 24 - Treating Depression With Deep Brain Stimulation Works—Most of the Time
Apr 24 - Parkinson’s disease shows links to depression
Apr 21 - TOLEDO Trial: Apomorphine Infusions Reduce 'Off' Time in Parkinson's Disease
Apr 21 - New drug provides long-awaited breakthrough for Parkinson's psychosis